Tiffany Lam
Managing Associate
Tiffany is a Managing Associate in the corporate practice in Hong Kong. Her practice focuses on capital markets, corporate finance, mergers and acquisitions and compliance advisory.
Managing Associate
Tiffany is a Managing Associate in the corporate practice in Hong Kong. Her practice focuses on capital markets, corporate finance, mergers and acquisitions and compliance advisory.
Languages - English, Mandarin, Cantonese
Jurisdictions - Hong Kong, England & Wales
Tiffany regularly acts for companies and investment banks in various corporate finance transactions, including Hong Kong initial public offerings, early-stage equity fundraisings, venture capital investments, mergers and acquisitions, secondary offerings, block trades and share placings. She is experienced in advising issuers, sponsors and underwriters in Hong Kong listings across a range of industries such as technology, life sciences and natural resources.
She also advises listed companies on governance and regulatory matters, including compliance with the Hong Kong Listing Rules, Takeovers Code and Securities and Futures Ordinance.
Prior to joining Stephenson Harwood, Tiffany was a solicitor at another major international law firm, and have worked in investment banking at Bank of America Merrill Lynch.
IPO on the Hong Kong Stock Exchange – 18A, Issuer side
Advised Cloudbreak Pharma Inc. (HK: 2592) on its HK$611 million IPO on the Main Board of the Hong Kong Stock Exchange.
IPO on the Hong Kong Stock Exchange – REIT, Sponsor side
Advised DBS, Credit Suisse and J.P. Morgan as underwriters on the HK$2.60 billion IPO of SF Real Estate Investment Trust (HK: 2191) on the Main Board of the Hong Kong Stock Exchange.
IPO on the Hong Kong Stock Exchange – Sponsor side
Advised China Industrial Securities, Halcyon Capital and other underwriters on the HK$104 million IPO of Impression Dahongpao Co., Ltd. (HK: 2695) on the Main Board of the Hong Kong Stock Exchange.
IPO on the Hong Kong Stock Exchange – Sponsor side
Advised Guotai Junan and other underwriters on the HK$272 million IPO of Wise Living Technology Co., Ltd. (HK: 2481) on the Main Board of the Hong Kong Stock Exchange.
IPO on the Hong Kong Stock Exchange – Issuer side
Advised JY Gas Limited (HK: 1407) on its HK$156 million IPO on the Main Board of the Hong Kong Stock Exchange.
Venture Capital
Advised Brizan Investments on its Series A investments into CYC Motor Holding Limited and GeneSense Technology Limited, respectively.
Share Placement
Advised China Industrial Securities as placing agent in the HK$490 million placing of shares by Inspur Digital Enterprise Technology Limited (HK: 596).
Rights Issue
Advised Pacific Century Premium Developments Limited (HK: 432) as the issuer in its HK$650 million rights issue.
Compliance Advisory
Advised MemeStrategy, Inc. (HK: 2440), JY Gas Limited (HK: 1407), Central China New Life Ltd. (HK: 9983) and Pacific Century Premium Developments Ltd. (HK: 432) on compliance with Hong Kong Listing Rules, the Takeovers Code and other Hong Kong laws and regulations.
Regulatory Investigation
Advised a Hong Kong listed company in relation to a SFC investigation and HKSE investigation, as well as resumption for trading and other related issues involving board reorganization.
